• Investor Presentation
• Fact Sheet
• Financial Information
  • Quarterly Results
  • Annual Reports/Proxy
  • SEC Filings
  • Financial News
• Stock Information
  • Stock Performance
  • Historic Stock Lookup
  • Investment Calculator
  • Analyst Coverage
• Shareholder Services
  • Investor FAQs
  • Shareholder Electronic Delivery
  • Contact Us
• Corporate Governance
  • Board of Directors
  • Committees & Charters
  • Insider Transactions
  • Insider Ownership

Investor Relations

The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

06-18-09
FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial

05-22-09
Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event

more »

Events

08-09-09
2009 4th Medical Biotech Forum

08-05-09
BMO Capital Markets 9th Annual Focus on Healthcare Conference

more »